Global Vitamin D Deficiency Disorders Clinical Trials Review, H1, 2016 – Analysis, Technologies & Forecasts Report … – Business Wire (press release)
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Vitamin
D Deficiency Disorders Global Clinical Trials Review, H1, 2016″
clinical trials to their offering.
The clinical trial report, Vitamin D Deficiency Disorders Global
Clinical Trials Review, H1, 2016″ provides an overview of Vitamin D
Deficiency Disorders clinical trials scenario. This report provides top
line data relating to the clinical trials on Vitamin D Deficiency
Disorders. Report includes an overview of trial numbers and their
average enrollment in top countries conducted across the globe. The
report offers coverage of disease clinical trials by region, country (G7
& E7), phase, trial status, end points status and sponsor type.
The report also provides prominent drugs for in-progress trials (based
on number of ongoing trials). These Clinical Trial Reports are generated
using a proprietary database – Pharma eTrack Clinical trials database.
Clinical trials are collated from 80+ different clinical trial
registries, conferences, journals, news etc across the globe. Clinical
trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.
Key Topics Covered:
- The report provides a snapshot of the global clinical trials landscape
The report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and
End point status
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment
- The report provides enrollment trends for the past five years
- The report provides latest news for the past three months
- Kirin Holdings Company, Limited
- Merck & Co., Inc.
- Ultragenyx Pharmaceutical Inc.
- OPKO Health, Inc.
- Laboratoires CRINEX
- Takeda Pharmaceutical Company Limited
- Laboratoires S.M.B S.A.
- Abbott Laboratories
- E. Merck KG
- DSM Biologics Holdings, Inc.
For more information visit http://www.researchandmarkets.com/research/wbml9j/vitamin_d